{
  "content": "39.\nHilleman DE, Spinler SA.Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.Pharmacotherapy.2002;22(1):66-7411794432Google ScholarCrossref\n40.\nMiller MR, McNamara RL, Segal JB. et al.Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.J Fam Pract.2000;49(11):1033-104611093570Google Scholar\n41.\nKhan IA, Mehta NJ, Gowda RM.Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation.Int J Cardiol.2003;89(2-3):239-24812767548Google ScholarCrossref\n42.",
  "source": "https://jamanetwork.com/journals/jama/fullarticle/208819",
  "chunk_id": "a39f55c7-4652-4ba5-9148-854b1f6dc176",
  "similarity_score": 0.4577808380126953,
  "query": "amiodarone cardioversion rhythm control atrial fibrillation conversion rate success",
  "rank": 14,
  "title": "Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications",
  "authors": "Patricia Vassallo, Richard G. Trohman",
  "year": "2007",
  "journal": "JAMA",
  "reference": "Vassallo, P., & Trohman, R. G. (2007). Prescribing amiodarone: An evidence-based review of clinical indications. JAMA, 298(11), 1312-1322. https://doi.org/10.1001/jama.298.11.1312",
  "doi": "10.1001/jama.298.11.1312",
  "chunk_index": 138,
  "total_chunks": 177,
  "retrieved_at": "2025-07-24T22:33:15.199036"
}